Riassunto
This user-friendly atlas demonstrates all of the major clinical applications of PET scanning. Its case-based approach-with teaching points, pitfalls, and "mimics"-presents all of the material in a concise and practical manner. And, correlative cross-sectional images illustrate the clinical features depicted in PET findings.
- Demonstrates the advantages and limitations of PET imaging in the investigation of cancer, neurological disorders, myocardial viability, and more.
- Delivers more than 1,100 state-of-the-art images of outstanding quality.
- Offers correlative plain film, MR, CT, ultrasound, and nuclear imaging studies to help readers recognize what various PET findings depict.
- Captures the wide range of normal and pathologic PET findings seen in all relevant body areas, and points out the many interpretation pitfalls, including normal and benign variants.
Contenuti
Chapter 1: The Basics of PET
Chapter 2: Approach to PET Image Interpretation, Normal Variants, and Benign Processes
Chapter 3: Lung Cancer
Case 1: SPN, positive, no other disease sites (proven adenocarcinoma).
Case 2: SPN, positive (proven adenocarcinoma).
Case 3: SPN, positive (proven recurrent squamous cell carcinoma).
Case 4: SPN, positive (proven large cell carcinoma).
Case 5: SPN, positive (proven squamous cell carcinoma).
Case 6: SPN, negative, tuberculoma.
Case 7: SPN, negative, aspergillosis.
Case 8: SPN, negative, cocci granuloma.
Case 9: SPN-positive, with hilar and/or mediastinal disease (proven large cell carcinoma).
Case 10: SPN, positive, with false positive mediastinal disease (proven squamous cell carcinoma).
Case 11: SPN-positive, with hilar and/or mediastinal disease (advanced aquamous cell carcinoma).
Case 12: Lung cancer staging, primary positive, no other disease (large cell undifferentiated carcinoma).
Case 13: Lung cancer staging, primary positive (proven adenocarcinoma).
Case 14: Lung cancer staging, primary only positive (NSCLC), coexisting infiltrative lung disease.
Case 15: Lung cancer staging, primary site only positive (proven squamous cell carcinoma).
Case 16: Lung cancer staging, with subtle mediastinal involvement (squamous cell carcinoma).
Case 17: Non-small cell lung cancer, with mediastinal involvement.
Case 18: Lung cancer staging, with mediastinal disease (large cell carcinoma).
Case 19: Lung cancer staging, with bone metastasis (adenocarcinoma).
Case 20: Lung cancer staging, with bone metastases (large cell malignancy).
Case 21: Lung cancer staging, Stage IV non-small cell lung cancer, with adrenal metastasis.
Case 22: Lung cancer, restaging post-treatment, with adrenal metastasis (large cell carcinoma).
Case 23: Squamous cell carcinoma, Stage IV, with axillary node involvement.
Case 24: Lung cancer (SCC), with chest wall invasion.
Case 25: Known lung cancer for staging, extensive disease (squamous cell carcinoma).
Case 26: Lung cancer staging, extensive disease (NSCLC).
Case 27: Lung cancer staging, small cell carcinoma.
Case 28: Lung cancer staging, localized pleural involvement (NSCLC and adenocarcinoma).
Case 29: Lung cancer staging, pleural adenocarcinoma.
Case 30: Non-small cell lung carcinoma, metastatic to pleura.
Case 31: Lung cancer restaging, treatment assessment (SCC).
Case 32: Lung cancer restaging, radiation therapy effects (SCC).
Case 33: Bilateral lung cancers.
Case 34: Breast carcinoma pulmonary metastases mimicking synchronous lung cancers.
Case 35: Bilateral lung cancers.
Case 36: Pitfall: Bronchoalveolar cell carcinoma.
Case 37: Pitfall: Bronchoalveolar cell carcinoma.
Case 38: Pitfall: Bronchoalveolar cell carcinoma.
Case 39: Pitfall: Lung cancer false positive, pulmonary infarct.
Case 40: Pitfall: lung cancer false positive, active tuberculosis.
Case 41: Pitfall: lung cancer false positive, sarcoidosis.
Case 42: Pitfall: Lung cancer, size limitation.
Chapter 4: Lymphoma
Case 1: Lymphoma, limited stage disease, staging.
Case 2: Lymphoma, staging, isolated neck disease.
Case 3: Lymphoma, staging and treatment assessment, pulmonary parenchymal involvement.
Case 4: Unexpected PET identification of limited stage visceral lymphoma.
Case 5: Bulky thoracic NSHD, initial staging and residual mass treatment assessment.
Case 6: Thoracic HD, initial staging and treatment assessment.
Case 7: Thoracic and abdominal HD: initial staging, treatment assessment, marrow activation.
Case 8: Lymphoma, nodal & visceral involvement, staging & treatment assessment, marrow activation.
Case 9: Recurrent lymphoma, bone marrow involvement.
Case 10: Recurrent pelvic NHL, radiation therapy follow-up.
Case 11: Mantle cell lymphoma, radiation response.
Case 12: Mediastinal recurrent lymphoma, response to chemotherapy.
Case 13: Mesenteric NHL, residual mass assessment.
Case 14: Lymphoma, staging & treatment assessment, head & neck presentation.
Case 15: Recurrent lymphoma, pediatric patient.
Case 16: Lymphoma follow-up, thymic rebound.
Chapter 5: Melanoma
Case 1: Staging, persistent disease at operative site
Case 2: Initial and re-staging, disease progression despite chemotherapy.
Case 3: Staging, unexpected additional disease site.
Case 4: Staging, multiple unexpected additional disease sites.
Case 5: Melanoma, restaging, solitary recurrent disease site (axilla).
Case 6: Restaging, recurrent facial disease.
Case 7: Restaging, progressive facial recurrences.
Case 8: Melanoma, restaging, lung and brain metastases.
Case 9: Restaging; lung, hilar, liver and osseous metastases.
Case 10: Restaging, extensive disease, treatment assessment.
Case 11: Restaging, advanced disease (carcinomatosis).
Chapter 6: Colorectal Cancer
Case 1: Initial staging, no additional disease site (rectal cancer).
Case 2: Initial staging, involved adjacent lymph node.
Case 3: Initial staging, distant metastases.
Case 4: Restaging, solitary liver metastasis.
Case 5: Restaging, recurrent hepatic metastasis.
Case 6: Restaging, solitary liver metastasis.
Case 7: Restaging, retroperitoneal nodal recurrence, assessment of post-treatment pre-sacral mass.
Case 8: Restaging, pelvic recurrences.
Case 9: Restaging, pre-sacral recurrence.
Case 10: Restaging, pulmonary parenchymal and pleural recurrences.
Case 11: Recurrent colorectal carcinoma, rising CEA, bone metastases.
Case 12: Colon cancer, liver metastasis, treatment effect (RF ablation).
Case 13: Liver metastasis, assessment of RF ablation efficacy.
Case 14: Liver metastases, surgical and interventional treatment effects.
Case 15: Liver metastases, chemotherapy efficacy.
Case 16: Pitfall: Recurrence, sub-centimeter lung metastases.
Case 17: Pitfall: Coexisting benign disease (viral axillary adenitis).
Chapter 7: Other Gastrointestinal Cancers
Case 1: Proximal esophageal squamous cell carcinoma.
Case 2: Distal esophageal adenocarcinoma, with gastro-hepatic nodal involvement.
Case 3: Esophageal carcinoma, superior mediastinal paraesophageal nodal involvement.
Case 4: Distal esophageal SCC.
Case 5: Distal esophageal adenocarcinoma, with gastric cardia extension and paragastric nodal involvement.
Case 6: Gastric carcinoma, with retroperitoneal nodal metastases.
Case 7: Gastric carcinoma, with peritoneal carcinomatosis.
Case 8: Pancreatic adenocarcinoma.
Case 9: Locally recurrent pancreatic carcinoma.
Case 10: Recurrent pancreatic carcinoma, metastatic to liver and brain.
Case 11: Ampullary adenocarcinoma, with local nodal involvement.
Case 12: Cholangiocarcinoma, with liver metastasis.
Case 13: Recurrent cholangiocarcinoma, drop metastasis.
Case 14: Suspected residual gallbladder carcinoma.
Chapter 8: Head and Neck Cancer
Case 1: Normal head and neck anatomy example.
Case 2: Glottic squamous cell carcinoma, initial diagnosis.
Case 3: Initial staging, BOT squamous cell carcinoma, with nodal metastasis at presentation.
Case 4: Locally advanced base of tongue squamous cell carcinoma, with bilateral necrotic lymph node metastases.
Case 5: Metastatic squamous cell carcinoma, cervical lymph node presentation, primary lesion search.
Case 6: Hard palate squamous cell carcinoma, radiation therapy planning.
Case 7: Recurrent maxillary non-small cell malignancy.
Case 8: Recurrent and progressive squamous cell carcinoma.
Case 9: Nasopharyngeal squamous cell carcinoma, with bone metastases.
Case 10: Squamous cell carcinoma, metastatic to thoracic spine, incipient cord compression presentation.
Chapter 9: Breast Cancer
Case 1: Focal breast activity due to an unsuspected breast cancer.
Case 2: Breast cancer, initial staging, axillary nodal presentation, primary search and internal mammary adenopathy.
Case 3: Breast cancer restaging, normal post-lumpectomy and radiation breast findings.
Case 4: Post surgical biopsy scar, post lumpectomy for infiltrating ductal carcinoma.
Case 5: Treated inflammatory breast cancer.
Case 6: Recurrent inflammatory breast cancer.
Case 7: Breast cancer restaging, in situ neoadjuvantly treated infiltrating lobular carcinoma, with diffuse blastic bone metastases.
Case 8: Breast cancer restaging, bone metastases.
Case 9: Breast cancer restaging, active bone metastases, treated liver metastases.
Case 10: Recurrent breast cancer, with extensive liver metatases.
Case 11: Breast cancer restaging, solitary liver metatasis.
Case 12: Recurrent breast cancer, with chest wall and lung parenchymal disease.
Case 13: Breast cancer restaging, axillary and chest wall involvement and bone metastases.
Case 14: Breast cancer restaging, extensive local and nodal recurrence.
Case 15: Breast cancer restaging, local and nodal recurrences in axilla, supraclavicular neck and mediastinum.
Case 16: Breast cancer restaging; mediastinal, neck and supraclavicular nodal recurrences.
Case 17: Breast cancer restaging, hilar nodal involvement, progression to liver and bone metastases.
Case 18: Restaging, thoracic (nodal and pulmonary parenchymal) metastases.
Case 19: Breast Cancer restaging, assessment of chemotherapy efficacy, mediastinal and bone metastases.
Chapter 10: Miscellaneous Tumors
Case 1: Recurrent thyroid carcinoma, lungs and neck.
Case 2: Recurrent thyroid carcinoma, isolated neck lymph node.
Case 3: Recurrent thyroid carcinoma to neck, low metabolic rate.
Case 4: Pitfall: Suspected recurrent thyroid carcinoma to mediastinum, false positive (thymus)
Case 5: In situ primary, presenting with pleural metastases
Case 6: Sarcomatoid renal cell carcinoma, with retroperitoneal metastases
Case 7: In situ primary, with IVC tumor extension
Case 8: Renal cell carcinoma, lung metastasis.
Case 9: Recurrent renal cell carcinoma, hilar and vertebral meta...
Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.